HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Donald J Kellerman Selected Research

zolmitriptan (Zomig)

5/2021Long term safety, tolerability, and efficacy of intracutaneous zolmitriptan (M207) in the acute treatment of migraine.
11/2020Development of a novel zolmitriptan intracutaneous microneedle system (Qtrypta™) for the acute treatment of migraine.
1/2019Efficacy of ADAM Zolmitriptan for the Acute Treatment of Difficult-to-Treat Migraine Headaches.
7/2018Use of Most Bothersome Symptom as a Coprimary Endpoint in Migraine Clinical Trials: A Post-Hoc Analysis of the Pivotal ZOTRIP Randomized, Controlled Trial.
1/2018Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine.
11/2017Rapid systemic delivery of zolmitriptan using an adhesive dermally applied microarray.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Donald J Kellerman Research Topics

Disease

7Migraine Disorders (Migraine)
05/2021 - 10/2013
4Pain (Aches)
01/2019 - 11/2017
3Nausea
01/2019 - 01/2018
2Headache (Headaches)
05/2021 - 01/2019
2Hyperacusis (Phonophobia)
07/2018 - 01/2018
2Photophobia (Light Sensitivity)
07/2018 - 01/2018
2Dry Eye Syndromes (Dry Eye Syndrome)
01/2004 - 01/2002
1Dizziness (Lightheadedness)
01/2018
1Paresthesia (Dysesthesia)
01/2018

Drug/Important Bio-Agent (IBA)

6zolmitriptan (Zomig)FDA Link
05/2021 - 11/2017
3Pain-FreeIBA
01/2019 - 01/2018
2Pharmaceutical PreparationsIBA
07/2018 - 11/2017
2diquafosolIBA
01/2004 - 01/2002
1Tryptamines (Triptans)IBA
01/2018
14-amino-TEMPO (A-TEMPO)IBA
10/2013
1Dihydroergotamine (Agit)FDA LinkGeneric
10/2013
1Purinergic P2Y2 ReceptorsIBA
01/2004
1Ophthalmic Solutions (Eye Drops)IBA
01/2002

Therapy/Procedure

1Treatment Delay
01/2019
1Metered Dose Inhalers (Metered Dose Inhaler)
10/2013
1Fluid Therapy (Oral Rehydration Therapy)
01/2004
1Therapeutics
01/2004